Evidence map›Paper›PMID 34960208›Full record

ArticleVaccines2021

Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study.

Xiaozhen Lai, He Zhu, Jiahao Wang, Yingzhe Huang, Rize Jing, Yun Lyu, Haijun Zhang, Huangyufei Feng, Jia Guo, Hai Fang

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A survey on Malaysian's acceptance and perceptions towards COVID-19 booster dose.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiaozhen LaiSchool of Public Health, Peking University, Beijing 100191, China.ORCID 0000-0001-8978-286X
He ZhuChina Center for Health Development Studies, Peking University, Beijing 100191, China.
Jiahao WangSchool of Public Health, Peking University, Beijing 100191, China.ORCID 0000-0001-7575-6580
Yingzhe HuangDepartment of Statistics and Modeling, Beijing Weikexing Technology, Beijing 100191, China.
Rize JingSchool of Public Administration and Policy, Renmin University of China, Beijing 100872, China.ORCID 0000-0002-1469-909X
Yun LyuSchool of Public Health, Peking University, Beijing 100191, China.
Haijun ZhangSchool of Public Health, Peking University, Beijing 100191, China.
Huangyufei FengSchool of Public Health, Peking University, Beijing 100191, China.
Jia GuoSchool of Public Health, Peking University, Beijing 100191, China.
Hai FangChina Center for Health Development Studies, Peking University, Beijing 100191, China.
Peking University · CNChinese Center For Disease Control and Prevention · CNRenmin University of China · CN

Funding

The Fundamental Research Funds for the Central Universities N/AThe Special Research Fund of Peking University (PKU) for the Prevention and Control of COVID-19 N/A
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) booster vaccination has been proposed in response to the new challenges of highly contagious variants, yet few studies have examined public acceptance of boosters. This study examined public acceptance of COVID-19 booster vaccination and its influencing factors by using the data from a self-administered online cross-sectional survey conducted in June 2021 in China. Multiple logistic analysis was used to examine the influencing factors of booster acceptance based on the health belief model (HBM). Among 1145 respondents, 84.80% reported to accept COVID-19 booster vaccination. Having COVID-19 vaccination history, perceiving high benefits and low barriers to booster vaccination, being younger (18-30 vs. 41-50), having a lower education level, being employed, and belonging to priority groups for vaccination were associated with increased odds of booster acceptance. The primary reason for refusing booster vaccination was concern about vaccine safety. The vast majority (92.8%) of respondents reported an annual willingness to pay between 0 and 300 CNY (0-46.29 USD) if the booster was not free. Our findings suggest that the acceptance rate of booster vaccination is relatively high in China, and the HBM-based analysis reveals that more efforts are needed to increase perceived benefits and reduce perceived barriers of vaccination to design effective and proper vaccination extension strategies when boosters become widely recommended.

Indexed as

booster vaccinationChinaCOVID-19health belief modelvaccine

Identifiers

PMID34960208
PMCPMC8709447
OpenAlexW4200586995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.